HUM vs MRK · P/E 39, rev $117.76B vs P/E 33, rev $65.01B
Humana Inc (HUM) versus Merck & Company Inc (MRK) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Not investment advice. Open the HUM and MRK stock pages for the full models.
Not investment advice.